Efficacy of Plasmid Elenagen in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Cancer

NCT05979298 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer
Platinum-resistant Ovarian Cancer

Interventions

DRUG: Gemcitabine
BIOLOGICAL: ELENAGEN

Sponsor

CureLab Oncology